# OnCo record btki-plus-venetoclax-fixed-duration (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/btki-plus-venetoclax-fixed-duration/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "btki-plus-venetoclax-fixed-duration" ;
  schema:name "BTK inhibitor + venetoclax, fixed duration"@en ;
  schema:description "Block the survival signal and remove the death shield at the same time, for about a year, then stop and stay in remission for years."@en ;
  schema:url <https://onco.cc/pairings/btki-plus-venetoclax-fixed-duration/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03836261>, <https://clinicaltrials.gov/study/NCT03462719> ;
  onco:cancers <https://onco.cc/cancers/cll/> ;
  onco:targets <https://onco.cc/targets/btk/>, <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/acalabrutinib/>, <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/zanubrutinib/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/sonrotoclax/> ;
  onco:trials <https://onco.cc/trials/amplify/>, <https://onco.cc/trials/glow/>, <https://onco.cc/trials/captivate/>, <https://onco.cc/trials/sequoia/>, <https://onco.cc/trials/celestial-tncll/> ;
  onco:pairs <https://onco.cc/drugs/acalabrutinib/>, <https://onco.cc/drugs/venetoclax/> .